The fallout from the ongoing war with Iran left its mark on every European equity market through March, though some have fared worse than others.
Source: US Top News and Analysis
Related Posts
Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week
The Swiss pharma giant is betting on a next-generation allergy treatment that may prove to…
Ask the Points Pro: I don’t want to pay a big annual fee for my travel card. What should I do?
A points expert explains the best cards for earning airline miles and how to avoid…
1.4 million filers face tax refund delays amid IRS paper check phaseout
Many filers are facing tax refund delays amid the IRS push to phase out paper…